Extrait

To assess clinical benefit (defined at 4 months as complete response, partial response or stable disease), safety and preserved geriatric independence. (main objective is a “bi-criteria” or composite criteria).

Critère d'inclusion

• Locally advanced or metastatic breast cancer over expressing HER2 and ≥ 70 years old

Liens

• euctr
• ictrp